Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
Abstract:
The present disclosure relates generally to conformation-specific antibodies that can bind to and neutralize the activity of phosphorylated-Threonine 231-tau protein (pT231-tau). The antibodies of the present technology are useful in methods for treating a neurological disorder associated with elevated cis-pT231-tau protein expression in a subject in need thereof.
Information query
Patent Agency Ranking
0/0